HOME ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE STORY OF OUR FIRM SEARCH

NIH Publication - Mesothelioma and Japan

Your malignant mesothelioma attorney provides this is an abstract of an article about Mesothelioma published at PubMed by the NIH.

Kyobu Geka. 2004 Dec;57(13):1233-5.

[Primary pericardial malignant mesothelioma with incomplete endocardial cushion defect; report of a case]

Okamoto T, Doi H, Yasuike J, Naitou K, Miyatake T, Sugiki K, Ohno T.

Department of Cardiovascular Surgery, Cardio-vascular Center Hokkaido Ohno Hospital, Sapporo, Japan.

Primary pericardial malignant mesothelioma is rare tumor and its prognosis is quite poor due to its late presentation and difficulty of complete resection. We describe a rare case of primary pericardial malignant mesothelioma in a 46-year-old female with incomplete endocardial cushion defect (ECD). Incidentally, we found 2 masses in the pericardial spaces after pericardiectomy. We have successfully removed these 2 masses en bloc and performed a total repair of incomplete ECD. Pathologically, these masses were a primary pericardial malignant mesothelioma. This patient is doing well 4 months after surgery without any evidence of recurrence despite reported poor prognosis of "primary pericardial malignant mesothelioma".

   Publication Types:

  • Case Reports


PMID: 15609664 [PubMed - indexed for MEDLINE]

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING

TABLE OF CONTENTS
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos


IN THIS SECTION
Farnesyltransferase Inhibitors
Cancer Immunotherapy
Great Britain
Poland
Pemetrexed Therapy
Sv40 Specific Recall Immunity
Polish Cases
Extra Pleural Pneumonectomy
Intraoperative Radiation Therapy
Calretinin
Hyaluronan
Granulocyte Colony Stimulating Factor
Canada
Pemetrexed (Alimta)
Calretinin Antibodies
Greece
Neoplasia
FDA Pemetrexed
Secreted Frizzled Related Protein
Tumor Necrosis
Podoplanin
Lymphohistiocytoid
Pathogenesis of Malignant Pleural
Diagnostic Difficulties
Mesothelioma from Adenocarcinoma
Mesothelial Proliferation
ThinPrep Cytospin
Effusion
Chemotherapy Options
Heparanase
Malignant Deciduoid
Mortality
Pemetrexed in Malignant Pleural Mesothelioma
Pleural Mesothelioma
Prognostic Analysis
Italian Mortality Rates
Vinorelbine and Oxaliplatin
DNA Methylation Profiles
Primary Malignant Pericardial Mesothelioma
Abdominal CAT Scans
China
Disseminated Malignant
Statistical Validation
Pathogenesis
Lung Adenocarcinoma
Japan


RETURN BACK TO
Mesothelioma
Latest News
see also:

Mortality Mesothelioma Publication speaks about mortality - Read on!
An abstract of an article about Mesothelioma and mortality

FDA Pemetrexed Malignant Pleural Mesothelioma Publication and FDA Pemetrexed
Abstract for Malignant Pleural Mesothelioma about FDA Pemetrexed

Mesothelioma National Institute Health Publication The National Institute of Health Mesothelioma Research Publications
Mesothelioma Publications from the National Institute of Health